Chengdu Easton Biopharmaceuticals Co Ltd (688513) — Capital Reinvestment Ratio
Chengdu Easton Biopharmaceuticals Co Ltd (688513) has a Capital Reinvestment Ratio of 0.40x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥61.35 Million) in capital expenditures (CN¥24.30 Million). See Chengdu Easton Biopharmaceuticals Co Ltd (688513) balance sheet quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Chengdu Easton Biopharmaceuticals Co Ltd Capital Reinvestment Ratio (2013–2025)
This chart tracks Chengdu Easton Biopharmaceuticals Co Ltd's Capital Reinvestment Ratio across 13 annual periods. Check 688513 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Chengdu Easton Biopharmaceuticals Co Ltd (2013–2025)
Year-by-year Capital Reinvestment Ratio for Chengdu Easton Biopharmaceuticals Co Ltd from 2013 to 2025. For live market cap and broader valuation context, see market value of Chengdu Easton Biopharmaceuticals Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.33x | CN¥264.94 Million | CN¥86.28 Million | ▼ -27.0% |
| 2024 | 0.45x | CN¥263.24 Million | CN¥117.42 Million | ▼ -29.9% |
| 2023 | 0.64x | CN¥275.25 Million | CN¥175.26 Million | ▼ -71.5% |
| 2022 | 2.23x | CN¥151.94 Million | CN¥339.33 Million | ▲ +28.6% |
| 2021 | 1.74x | CN¥147.60 Million | CN¥256.29 Million | ▲ +36.7% |
| 2020 | 1.27x | CN¥156.52 Million | CN¥198.81 Million | ▲ +88.8% |
| 2019 | 0.67x | CN¥141.83 Million | CN¥95.41 Million | ▲ +46.4% |
| 2018 | 0.46x | CN¥166.79 Million | CN¥76.63 Million | ▲ +71.0% |
| 2017 | 0.27x | CN¥85.70 Million | CN¥23.02 Million | ▲ +59.8% |
| 2016 | 0.17x | CN¥106.06 Million | CN¥17.83 Million | ▼ -76.0% |
| 2015 | 0.70x | CN¥50.57 Million | CN¥35.43 Million | ▲ +48.5% |
| 2014 | 0.47x | CN¥46.71 Million | CN¥22.04 Million | ▼ -82.6% |
| 2013 | 2.71x | CN¥28.12 Million | CN¥76.11 Million | — |